Heron Therapeutics Inc vs NXP Semiconductors N.V. Common Stock — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $68.01M), while NXP Semiconductors N.V. Common Stock trades at $233 (market cap $58.27B). The key difference: NXP Semiconductors N.V. Common Stock is far larger — about 856.8× Heron Therapeutics Inc's market cap, and NXP Semiconductors N.V. Common Stock pays a 1.76% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and NXP Semiconductors N.V. Common Stock for 0 Days on average.
| HRTX | NXPI | |
|---|---|---|
Market Cap | $68.01M | $58.27B |
Volume | 1,891,941 | 3,950,702 |
Sector | Health | Technology |
52-Week High | $1.49 | $332.67 |
52-Week Low | $0.27 | $184.19 |
Typical Hold Time | 35 Days | 0 Days |
Enterprise Value | $174.75M | $66.38B |
Dividend Yield | — | 1.76% |
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) is trading at $0.39, up 17.58% today, with a bullish technical outlook from moving averages but mixed signals from oscillators. The company maintains strong gross margins of 70.07% but continues to report net losses, with Q2 2026 missing both EPS and revenue expectations. Analyst sentiment remains overwhelmingly positive with 89% buy ratings despite recent earnings disappointments and negative profitability metrics.
While analyst consensus is strongly bullish, HRTX faces significant fundamental challenges including consistent net losses, negative ROE of -78.72%, and cash flow concerns. The stock's current momentum appears driven by technical factors rather than improving fundamentals, creating a high-risk investment profile that requires careful monitoring of upcoming Q3 earnings and revenue stabilization efforts.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.
Read more on NXPI →